FDA Proposes Inclusion of Bemotrizinol in U.S. Sunscreens for Enhanced UV Protection
The U.S. Food and Drug Administration (FDA) has proposed allowing the use of Bemotrizinol, a sunscreen ingredient already prevalent in Europe, Australia, and Asia, in American sunscreen products. This chemical is recognized for its broad-spectrum protection against both UVA and UVB rays, offering potentially superior protection compared to current U.S.-approved ingredients. FDA Commissioner Marty Makary criticized the slow pace of U.S. regulatory processes, which have left American consumers with fewer sunscreen options than those available internationally. The proposal would permit Bemotrizinol to be used in concentrations up to 6% in sunscreen formulations. Acting Director of the U.S. Office of Nonprescription Drugs, Karen Murry, expressed optimism about the inclusion of Bemotrizinol, highlighting the potential for more timely access to effective over-the-counter products. 
